Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ACTRN12625000922471) titled 'A Randomised Controlled Trial Investigating Intrauterine Platelet-Rich Plasma in Women with Repeated Implantation Failure' on Aug. 25.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Type of endpoint: Efficacy
Primary Sponsor: The Royal Women's Hospital, Melbourne
Condition:
Infertility
Infertility
Reproductive Health and Childbirth - Fertility including in vitro fertilisation
Intervention:
Platelet Rich Plasma (PRP) is an autologous blood product enriched with growth factors and cytokines. PRP is cr...